At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 98 enrolled
Drug / intervention
Paracervical Nerve Block +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Pain Control With Hormonal IUS Insertion (SOPHI Study)
In Brief
A Phase 4 clinical trial evaluating Paracervical Nerve Block and Sham Paracervical Block for Pain. Completed, enrolled 98 participants across 3 sites.
Detailed Summary
This study aims to compare pain during insertion of the Skyla® IUS using a 100mm visual analog scale (VAS) among 92 young women aged 14 to 22 years randomized to receive a paracervical (n=46) block versus a sham paracervical block (n=46).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsBayer, University of Pennsylvania
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedFeb 2015
Primary CompletionJul 2016
TodayJul 2026
First PostedFeb 2, 2015
Enrollment StartJan 1, 2015
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 11.4 years ago
Interventions
Paracervical Nerve Blockdrug
Block randomization to receive lidocaine paracervical nerve block vs sham cervical block
Sham Paracervical Blockdrug
Block randomization to receive lidocaine paracervical nerve block vs sham cervical block